IGA

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

Retrieved on: 
Monday, March 20, 2023
Clinical and Experimental Dermatology, Civil service commission, Ichthyosis, CI, Aes, XLRI, Quality of life, Associate, British Association of Dermatologists, Yale School of Medicine, IGA, CONTROL, Patient, CED, PP, X-linked ichthyosis, Isotretinoin, ITT, NYSE, European Commission, Safety, ARCI, Disease, Pharmaceutical industry, Dermatology

BASKING RIDGE, NJ, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced the online publication of a sub-analysis of the Phase 2b CONTROL study in Clinical and Experimental Dermatology (CED), the educational journal of the British Association of Dermatologists. The CONTROL study evaluated TMB-001, a topical isotretinoin formulated using the Company’s patented IPEG™ delivery system, in subjects nine years of age and older with moderate to severe congenital ichthyosis (CI).

Key Points: 
  • The CONTROL study evaluated TMB-001, a topical isotretinoin formulated using the Company’s patented IPEG™ delivery system, in subjects nine years of age and older with moderate to severe congenital ichthyosis (CI).
  • CI is a group of rare genetic keratinization disorders that lead to dry, thickened, and scaling skin.
  • “In this sub-analysis, participants in the CONTROL study with ARCI and XLRI mostly showed comparable percentage differences in responses to treatment with a novel topical isotretinoin formulation versus vehicle.
  • The intent-to-treat (ITT) population consisted of all randomized participants who received one or more doses of the study medication.

Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms

Retrieved on: 
Saturday, March 18, 2023
Health, Other Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Maintenance, Psoriasis Area and Severity Index, EASI, Week, Dermatology, American Academy, Atopic dermatitis, IGA, 2008 Giro d'Italia, Stage 1 to Stage 11, Patient, Itch, AD, Skin, Inflammation, Vaccine

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, announced that data from Stage 1 of the ongoing pivotal CBP-201 China trial in moderate-to-severe atopic dermatitis (AD) showed rapid relief from symptoms, as early as week one in some cases, and no efficacy plateau at Week 16.

Key Points: 
  • Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, announced that data from Stage 1 of the ongoing pivotal CBP-201 China trial in moderate-to-severe atopic dermatitis (AD) showed rapid relief from symptoms, as early as week one in some cases, and no efficacy plateau at Week 16.
  • In the study “CBP-201, a next-generation IL-4Rα antibody, achieved all primary and secondary efficacy endpoints in the treatment of adults with moderate-to-severe atopic dermatitis (AD): A randomized, double-blind, pivotal trial in China (CBP-201-CN002),” researchers reported on results from Stage 1 of the pivotal China trial of CBP-201 in moderate-to-severe AD.
  • Patients on active therapy experienced rapid relief of symptoms, with a reduction in itch at Week 1 and significant improvement in all study endpoints by Week 4, which was sustained to Week 16.
  • “We are honored to have data from our two CBP-201 atopic dermatitis studies at the prestigious American Academy of Dermatology Annual Meeting, showing rapid and sustained relief,” said Zheng Wei, Ph.D., Co-founder and CEO of Connect Biopharma.

LEO Pharma Presents Late-Breaking Positive Phase 3 Results of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (CHE) at AAD 2023

Retrieved on: 
Saturday, March 18, 2023
Managed Care, Pharmaceutical, Health, Clinical Trials, Janus, American Academy of Dermatology, American Academy, JAK, IGA, Leo Pharma, Patient, AAD, CHE, DELTA, Week, Safety, LEO, Pharmaceutical industry, Silviculture

The DELTA 1 trial randomized 487 adults with moderate-to-severe CHE to twice-daily delgocitinib cream 20 mg/g (n=325) or cream vehicle (n=162) for 16 weeks followed by a 36-week extension trial.

Key Points: 
  • The DELTA 1 trial randomized 487 adults with moderate-to-severe CHE to twice-daily delgocitinib cream 20 mg/g (n=325) or cream vehicle (n=162) for 16 weeks followed by a 36-week extension trial.
  • A significantly greater proportion of delgocitinib-treated patients, compared to cream vehicle, achieved this IGA-CHE improvement (19.7% vs. 9.9%; p=0.006).
  • A significantly greater proportion of delgocitinib-treated patients achieved a ≥75% improvement in Hand Eczema Severity Index (HECSI-75) compared to cream vehicle (49.2% vs. 23.5%; p
  • We are incredibly excited to share the positive results of this trial, which demonstrates the potential that delgocitinib cream has as a first-in-class innovative topical treatment.”

Interblock to Exhibit Ground-Breaking Technology at IGA 2023

Retrieved on: 
Friday, March 17, 2023
Diamond, San Diego Convention Center, Roulette, ETG, Convention, Dice, IGA, Knowledge, Environment, Video game, Casino, Craps

Interblock will demonstrate new forms of technology designed to rise Casinos to the top of the competitive gaming industry landscape at IGA 2023.

Key Points: 
  • Interblock will demonstrate new forms of technology designed to rise Casinos to the top of the competitive gaming industry landscape at IGA 2023.
  • Interblock projects its booth, featuring innovative products and a meticulously crafted layout, will incite customer enthusiasm at IGA 2023.
  • “IGA 2023 provides Interblock the opportunity to meet with and demonstrate our commitment to our Native Indian Gaming partners,” said Peter Herem, Vice President of Interblock’s US Sales Team.
  • “Native Indian Gaming is critical to Interblock’s success, and we look forward to bringing our latest developments and innovations to IGA 2023 including our latest Live ETG pit technology.

Andrew Cardno to Speak at the Indian Gaming Association about Protecting Sovereignty and Your Data

Retrieved on: 
Thursday, March 16, 2023
The Co Founder, Conference, National Indian Gaming Association, SAN, Housing, IGA, Cornerstone, San Diego Convention Center, Government, General counsel, State government, QCI, Tax, Intelligence

Panelist Andrew Cardno, Stasi Baran and Steve Bodmer will be speaking at the upcoming IGA Conference about the importance of tribal data sovereignty and how to protect it.

Key Points: 
  • Panelist Andrew Cardno, Stasi Baran and Steve Bodmer will be speaking at the upcoming IGA Conference about the importance of tribal data sovereignty and how to protect it.
  • Cardno, the Co-Founder and CTO of Quick Custom Intelligence, will detail five steps you can take to protect your data sovereignty.
  • Consider the example where in ten years a state government decides to impose a tax on the use of tribal gaming data.
  • More information about the IGA event is available on this link: Indian Gaming Tradeshow & Convention 2023 | Indian Gaming Association

BIO-key and BeyondTrust Announce Integrated Partnership to Offer Identity-Bound Biometrics to Enhance Security for Privileged Remote Access

Retrieved on: 
Tuesday, March 14, 2023
Zero trust security model, International, IAM, Access management, Trust, Ecosystem, Identity, Identity Governance Framework, Partnership, IGA, Administration, IBB, BeyondTrust, Identity management, PAM, As a service, Channel, Online shopping, WALL

Remote access pathways are targets for cyber attackers, who use them to compromise data and attain unauthorized access to IT networks.

Key Points: 
  • Remote access pathways are targets for cyber attackers, who use them to compromise data and attain unauthorized access to IT networks.
  • Weak authentication methods, such as improperly managed passwords, security questions that can be easily guessed by hackers, phone-based methods, and security tokens are unable to positively identify the person requesting access.
  • BIO-key’s PortalGuard, integrated with BeyondTrust’s Privileged Remote Access solution that controls, manages, and audits the access of privileged employees, vendors, developers, and cloud ops engineers, now offers BeyondTrust customers a wide range of flexible authentication options, including Identity-Bound Biometrics (IBB) .
  • “The BeyondTrust Technology Alliance Program enables integrations with BeyondTrust Privileged Access Management (PAM) solutions so that customers can maximize the value of their IT security investments,” said David Manks, VP Strategic Alliances of BeyondTrust.

Elevate Security Eliminates Hidden Risks in Identity & Access Management

Retrieved on: 
Wednesday, March 15, 2023
Software, Technology, Security, Software as a service, IAM, Microsoft, Access management, Microsoft Azure, Risk, Identity Governance Framework, Azure, Pernicious, Elevate, IGA, Computer security, Hand, Research, White House, White, Data, TAG, Policy, Access, Scalability, Identity management, Identity, Online shopping, Risk management

Elevate Security today announced the release of Elevate Identity, its SaaS offering for Identity and Access Management (IAM) Professionals.

Key Points: 
  • Elevate Security today announced the release of Elevate Identity, its SaaS offering for Identity and Access Management (IAM) Professionals.
  • Additionally, the Elevate Identity service integrates with Identity Governance tools such as Sailpoint’s Identity Security Platform to automate personalized access reviews based on changes in an individual’s user risk profile.
  • In its recent Executive Order on Improving the Nation’s Cybersecurity , the White House called on Federal agencies to urgently reexamine and up-level identity, credential, and access management capabilities.
  • Elevate Identity has been shown to pay for itself in less than one year through a 20-50% reduction in security incidents involving a negligent employee or contractor.

Alcor to showcase AccessFlow IGA product capabilities during Speaker Session at Gartner IAM Summit 2023

Retrieved on: 
Tuesday, March 14, 2023
SAN, IAM, Alcor, Booth, ServiceNow, Administration, IGA, SOC, Identity, Identity Governance Framework, Risk management, Trust, Organization

Meet Alcor at Booth #136 at Gartner IAM Summit from March 20-22, 2023 in Grapevine, TX to learn about AccessFlow IGA.

Key Points: 
  • Meet Alcor at Booth #136 at Gartner IAM Summit from March 20-22, 2023 in Grapevine, TX to learn about AccessFlow IGA.
  • Alcor will be present at booth number 136 where attendees can learn more about our industry-leading Identity Governance and Administration Solution, AccessFlow IGA.
  • In addition, Alcor will be hosting a speaker session "Propel Enterprise Identity Governance and Administration to the Next Level", featuring Pulkit Agrawal, Product Manager at Alcor.
  • For more information on Alcor Solutions, please visit our website at www.alcortech.com , and follow us on LinkedIn , Twitter , and Facebook .

Online Classified Ad Platform Market to grow by USD 16.1 billion from 2021 to 2026, horizontal segment to be a significant contributor to the market growth - Technavio

Retrieved on: 
Tuesday, March 14, 2023
Online, RTB, Social media, Sample, DSPS, Request, Geography, USD, SSPS, LED, ROI, Research, Electronics, IGA, Advertising, Car, Growth, Digital, Smartphone, Video game, Food delivery, Mobile phone, Auction, Bridge

Therefore, these factors of the horizontal model drive the online classified ad platform market growth during the forecast period.

Key Points: 
  • Therefore, these factors of the horizontal model drive the online classified ad platform market growth during the forecast period.
  • By geography, the global online classified ad platform market is segmented into North America, APAC, Europe, Middle East and Africa, and South America.
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global online classified ad platform market.
  • The fast-growing online advertisement market facilitates the online classified ad platform market growth in APAC over the forecast period.

Aristocrat Gaming Brings INNOVATION in MOTION to IGA 2023

Retrieved on: 
Monday, March 13, 2023
Universe, Blue Skies, Aristocracy (class), Hold, Neptune, Hunting, Gold, XL, Convention, IGA, Aristocrat Leisure, Collection, Video game, Animal husbandry

LAS VEGAS, March 13, 2023 /PRNewswire/ -- It's all about "INNOVATION IN MOTION" for Aristocrat Gaming™ at the Indian Gaming Tradeshow & Convention (IGA) 2023 as the company plans to bring a diverse, industry-leading portfolio of next-generation cabinets, games, and features, along with 80 percent custom content specifically for Class II tribal customers. 

Key Points: 
  • LAS VEGAS, March 13, 2023 /PRNewswire/ -- It's all about "INNOVATION IN MOTION" for Aristocrat Gaming™ at the Indian Gaming Tradeshow & Convention (IGA) 2023 as the company plans to bring a diverse, industry-leading portfolio of next-generation cabinets, games, and features, along with 80 percent custom content specifically for Class II tribal customers.
  • "We are excited to showcase our commitment to Class II gaming content at IGA, ensuring our tribal customers have a variety of fresh content to diversify their floor and appeal to new and current players alike," said Jon Hanlin, senior vice president of commercial strategy Americas and EMEA for Aristocrat Gaming.
  • "Aristocrat Gaming is continuously investing in innovation throughout our hardware and product portfolios, elevating our games to new and exciting places to meet and exceed player demand."
  • The new game family has been configured for Class II play while maintaining the original essence of the game.